Bill

Bill > A2839


NJ A2839

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.


summary

Introduced
02/28/2022
In Committee
06/27/2023
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.

AI Summary

This bill requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers, and limits cost sharing for health insurance coverage of insulin. Specifically, it mandates that health insurance plans cover at least one epinephrine auto-injector device and a prescription asthma inhaler, with no deductible and limited copayments or coinsurance. It also caps the cost-sharing for insulin at $35 per 30-day supply. These provisions apply to individual and group health insurance plans as well as plans offered through the State Health Benefits Program and School Employees' Health Benefits Program.

Committee Categories

Budget and Finance, Business and Industry, Health and Social Services

Sponsors (20)

Last Action

Substituted by S1614 (2R) (on 06/30/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...